PrimeVigilance Receives Queen’s Award for Enterprise
pharmafile | April 23, 2014 | News story | |
PrimeVigilance Limited (PrimeVigilance), the specialist pharmacovigilance service provider, has been honoured with the Queen’s Award for Enterprise 2014 in the International Trade Category. PrimeVigilance has received the accolade – which is the highest official award for business success in the UK – in recognition of achieving substantial overseas earnings with growth and commercial success for the last six years.
PrimeVigilance is a leader in providing pharmacovigilance and medical information
services for national and multi.national pharmaceutical companies worldwide. It
has clients based in Europe, North America, Australia and Asia/Pacific Rim
providing a global service that currently covers more than 100 countries and over
150 medicinal products.
PrimeVigilance has been awarded the Queen’s Award for International Trade for
outstanding growth in overseas earnings of 173% over the last three years. In
addition, the company has entered a number of new markets in this period
including Australia, Germany, Spain, Switzerland and the Scandinavian countries.
Neil Clark, Chief Executive Officer of PrimeVigilance commented, “PrimeVigilance has grown substantially since it was founded six years ago and this award is testament to the high quality service we provide to our customers around the world. The Queen’s Award is a great honour not just for the company but for all of our individual employees internationally who have helped contribute to the company’s success. We look forward to building on our success and achieving further growth in the future.”
The Queen’s Awards for Enterprise is a prestigious awards programme for British
businesses and organisations that excel at trade, innovation or sustainable
development. The awards are made annually by HM The Queen, and are only
given for the highest levels of excellence demonstrated in each category. They
are judged to a demanding level and winners receive a number of benefits and
worldwide recognition.
